CARDIOVASCULAR: Wednesday, September 5th - European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria

Wednesday, September 5th - European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria 1. Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results STEFANO GHIO, San Matteo University Hospital, Italy COMMENT: CECILIA LINDE, Karolinska University Hospital, Stockholm REFERENCE: Hotline III, 3222 page 315 The standard echocardiographic criteria for selecting patients to receive cardiac resynchronisation are not adequate according to Stefano Ghio. During the ESC Congress in Vienna he presented results from the PROSPECT trial and afterwards he talked with Sarah Maxwell. Cecilia Linde gave Nicola Solomon her comments on the findings. 2. Selective Invasive Treatment Best for Women with Non-ST Elevation Acute Coronary Syndromes EVA SWAHN, University Hospital Linköping, Sweden COMMENT: ECKART FLECK, Deutsches Herzzentrum, Berlin REFERENCE: HOTLINE II, Monday 8am Women who undergo selective invasive treatment for non-ST elevation acute coronary syndromes do better than those who receive routine early invasive treatment. This is according to the OASIS 5 study from Sweden that randomised women to either of the two approaches. The findings suggest that females with non-ST elevation ACS should be approached differently from their male counterparts. Sarah Maxwell interviewed OASIS investigator Eva Swahn at the ESC meeting in Vienna. Eckart Fleck of the Deutsches Herzzentrum in Berlin gave his comments on her comments to Derek Thorne. 3Patients with High Restenosis Risk Benefit More from Drug Eluting Stents RAUL MORENO, University Hospital La Paz, Madrid REFERENCE: Abstract 3103 Results from a large meta analysis suggest that drug eluting stents have a greater benefit when the risk of restenosis increases. This could affect the “off label” use of these stents. Raul Moreno, of the University Hospital La Paz, Madrid, discussed his findings with Derek Thorne.